Unknown

Dataset Information

0

Crystal structure of 13-(2-meth-oxy-phenyl)-3,4-di-hydro-2H-indazolo[1,2-b]phthalazine-1,6,11(13H)-trione.

ABSTRACT: In the title compound, C22H18N2O4, the three fused rings of the pyrazolo-phthalazine moiety are coplanar (r.m.s. deviation = 0.027?Å). The cyclo-hexene ring fused to the pyrazolidine ring, so forming the indazolophthalazine unit, has a half-chair conformation. The benzene ring is almost normal to the mean plane of the pyrazolo-phthalazine moiety, with a dihedral angle of 87.21?(6)° between their planes. In the crystal, mol-ecules are linked by pairs of C-H?O hydrogen bonds forming inversion dimers. The dimers are linked via C-H?? inter-actions, forming slabs parallel to (100). Between the slabs there are weak ?-? inter-actions [shortest inter-centroid distance = 3.6664?(9)?Å], leading to the formation of a three-dimensional structure.

SUBMITTER: Bouraiou A 

PROVIDER: S-EPMC4571420 | biostudies-literature | 2015 Aug

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Crystal structure of 13-(2-meth-oxy-phenyl)-3,4-di-hydro-2H-indazolo[1,2-b]phthalazine-1,6,11(13H)-trione.

Bouraiou Abdelmalek A   Bouacida Sofiane S   Merazig Hocine H   Chibani Aissa A   Bouaziz Zouhair Z  

Acta crystallographica. Section E, Crystallographic communications 20150725 Pt 8

In the title compound, C22H18N2O4, the three fused rings of the pyrazolo-phthalazine moiety are coplanar (r.m.s. deviation = 0.027 Å). The cyclo-hexene ring fused to the pyrazolidine ring, so forming the indazolophthalazine unit, has a half-chair conformation. The benzene ring is almost normal to the mean plane of the pyrazolo-phthalazine moiety, with a dihedral angle of 87.21 (6)° between their planes. In the crystal, mol-ecules are linked by pairs of C-H⋯O hydrogen bonds forming inversion dime  ...[more]

Similar Datasets

Unknown Crystal structure of 13-phenyl-2,3,4,13-tetra-hydro-1H-indazolo[1,2-b]phthalazine-1,6,11-trione.
| S-EPMC4719966 | biostudies-literature
Unknown 8-Meth-oxy-3-methyl-3,4-di-hydro-2H-1,3-benzoxazine.
| S-EPMC3884293 | biostudies-literature
Unknown 3,3'-(Ethane-1,2-diyl)bis(6-meth-oxy-3,4-dihydro-2H-1,3-benzoxazine) mono-hydrate.
| S-EPMC3435746 | biostudies-literature
Unknown 7-Meth-oxy-3,4-dihydro-naphthalen-1(2H)-one.
| S-EPMC3152045 | biostudies-literature
Unknown Crystal structure of (E)-4-ethyl-2-(4-meth-oxy-benzyl-idene)-3,4-di-hydro-naphthalen-1(2H)-one.
| S-EPMC4459325 | biostudies-literature
Unknown (6S*)-6-[(1S*,2R*)-1,2-Di-hydroxy-pent-yl]-4-meth-oxy-5,6-di-hydro-2H-pyran-2-one.
| S-EPMC3884319 | biostudies-literature
Unknown (1E)-6-Meth-oxy-3,4-dihydro-naphthalen-1(2H)-one oxime.
| S-EPMC2983376 | biostudies-literature
Unknown Bis(4-meth-oxy-3,4-di-hydro-quinazolin-1-ium) chloranilate.
| S-EPMC3884394 | biostudies-literature
Unknown {6-[2,5-Bis(chloro-meth-yl)-3,4-dihydroxy-tetra-hydro-furan-2-yl-oxy]-3-chloro-4,5-dihydr-oxy-3,4,5,6-tetra-hydro-2H-pyran-2-yl}methyl acetate dihydrate.
| S-EPMC2980221 | biostudies-literature
Unknown Crystal structure of (E)-2-[(2-bromopyridin-3-yl)methyl-idene]-6-meth-oxy-3,4-di-hydro-naphthalen-1(2H)-one and 3-[(E)-(6-meth-oxy-1-oxo-1,2,3,4-tetra-hydro-naphthalen-2-ylidene)meth-yl]pyridin-2(1H)-one.
| S-EPMC4992914 | biostudies-literature